02 Dec, 16:14 - Indian

SENSEX 80248.08 (0.56)

Nifty 50 24276.05 (0.60)

Nifty Bank 52109 (0.10)

Nifty IT 43547 (0.93)

Nifty Midcap 100 57000.85 (1.08)

Nifty Next 50 71164.35 (0.62)

Nifty Pharma 22450.2 (0.94)

Nifty Smallcap 100 18845.05 (1.04)

02 Dec, 16:14 - Global

NIKKEI 225 38513.02 (0.80)

HANG SENG 19550.29 (0.65)

S&P 6054.75 (-0.14)

Login/Signup

You are Here : Home > Research

31-Jan-2024

Dr Reddys Laboratories

NP up 11.01%

'For the quarter ending Dec 2023, consolidated Net sales (including other operating income) of Dr Reddys Laboratories has increased 6.58% to Rs 7236.8 crore compared to quarter ended Dec 2022.  Sales of Pharmaceutical Services segment has gone up 2.68% to Rs 1,058.00 crore (accounting for 14.12% of total sales).  Sales of Global Generics segment has gone up 6.49% to Rs 6,312.40 crore (accounting for 84.26% of total sales).  Sales of Others segment has gone up 73.08% to Rs 121.50 crore (accounting for 1.62% of total sales).  Inter-segment sales rose Rs 238.40 crore to Rs 255.10 crore.  

Profit before interest, tax and other unallocable items (PBIT) has jumped 5.26% to Rs 4,220.70 crore.  PBIT of Pharmaceutical Services segment rose 63.27% to Rs 230.70 crore (accounting for 5.47% of total PBIT).  PBIT of Global Generics segment rose 2.15% to Rs 3,907.70 crore (accounting for 92.58% of total PBIT). &...



Pleaselogin & subscribe to view the full report.

More Reports
More Reports View Company Information